Genetic Testing Denial Management: Streamlining Appeals for Genomics Services

Klivira automates genetic testing denial management, transforming a complex, high-touch workflow into an efficient, data-driven process.

Denials for genetic testing, including hereditary cancer panels, prenatal screening, and pharmacogenomics, present unique challenges. High-cost tests, evolving medical necessity criteria, and frequent routing to RBMs like eviCore and Avalon Healthcare Services contribute to significant administrative burden and revenue leakage. Effective denial management is critical for maintaining financial health and ensuring patient access to vital genomic insights.

The Unique Landscape of Genetic Testing Denials

Genetic testing often involves complex medical necessity reviews, frequently managed by specialized RBMs. Denials typically stem from insufficient documentation, lack of clear clinical utility in the payer's policy, or coding discrepancies. The high average cost of these services means each denial represents a substantial financial impact, demanding a precise and timely appeal strategy.

Klivira's Automated Denial Management for Genetic Testing

Klivira's platform integrates multi-channel denial ingestion, including X12 835 and X12 277 transactions, alongside Da Vinci PAS ClaimResponse for PAS-conformant payers. This comprehensive intake ensures no denial is missed, providing a unified view of all genetic testing-related denials regardless of origin. Our system normalizes X12 CARC/RARC codes and payer-specific variations into a consistent taxonomy, enabling accurate categorization and routing for genetic testing services.

Key Automation Features for Genetic Testing Appeals

**Automated Appeal Packet Assembly:** For clinical-necessity denials common in hereditary cancer panels or pharmacogenomics, Klivira pulls relevant clinical documentation from the EMR via FHIR, including genetic counseling notes, lab results, and family history, ensuring payer-specific requirements are met.
**Payer-Specific Appeal Logic:** Our system applies payer and RBM-specific appeal pathways, routing genetic testing denials to the correct appeal level (e.g., first-level appeal, peer-to-peer review) based on normalized denial reasons and established guidelines like NCCN or ASCO.
**Timely Filing Enforcement:** Proactive tracking and alerts for per-payer timely-filing windows prevent missed deadlines for complex genetic testing appeals, a common failure point in manual workflows.
**Root-Cause Analysis & Feedback:** Klivira identifies recurring denial patterns by payer, RBM (e.g., eviCore, Avalon Healthcare Services), and specific genetic test type. This data feeds back into upstream prior authorization submissions, improving accuracy and reducing future denials for high-volume categories like prenatal genetic testing.

Addressing Common Genetic Testing Denial Failure Modes

Manual genetic testing denial management is prone to errors such as misinterpreting complex CARC/RARC codes, missing timely-filing deadlines for multi-stage appeals, and submitting incomplete documentation. Klivira's automated workflow mitigates these risks by providing normalized denial reason parsing, systematic tracking, and intelligent document discovery, ensuring every appeal for genetic testing is robust and compliant.

Integration and Standards Compliance

Klivira leverages industry standards to streamline genetic testing denial management. Our platform ingests X12 835 and X12 277 transactions for comprehensive denial intake and supports Da Vinci PAS ClaimResponse for modern payer interactions. EMR integration via FHIR ensures seamless access to clinical data for appeal packet assembly, maintaining data integrity and reducing manual data entry for genetic testing workflows.

Frequently asked questions

How does Klivira handle denials from RBMs like eviCore or Avalon Healthcare Services for genetic tests?

Klivira's system is configured with specific logic for RBMs such as eviCore and Avalon Healthcare Services. We normalize their denial codes and policy variations, then automate the routing and documentation assembly according to their unique appeal pathways, ensuring compliance and efficiency.

What types of clinical documentation does Klivira automate for genetic testing appeals?

For genetic testing appeals, Klivira automatically pulls relevant clinical documentation from the EMR via FHIR. This includes genetic counseling notes, specific test results, family history, and any updated problem lists, ensuring the appeal packet is complete and aligned with clinical guidelines like NCCN or ASCO.

Can Klivira help identify the root causes of genetic testing denials?

Yes, Klivira provides robust reporting and pattern detection for genetic testing denials. Our platform surfaces trends by payer, RBM, and specific test type, allowing your team to identify common root causes and refine upstream prior authorization processes for hereditary cancer panels, prenatal, or pharmacogenomics tests.

How does Klivira ensure timely filing for complex genetic testing appeals?

Klivira enforces per-payer timely-filing windows for genetic testing appeals. Our system proactively tracks appeal status, provides alerts for upcoming deadlines, and auto-escalates when status remains unchanged, significantly reducing the risk of missed appeal windows.

Does Klivira integrate with our existing EMR for genetic testing denial management?

Yes, Klivira integrates with major EMRs using SMART on FHIR standards. This integration allows for seamless pulling of clinical documentation for appeal packets and writing back appeal outcomes to the patient's chart, streamlining the entire genetic testing denial management workflow.